At this time, posts about iCure are rapidly increasing on portals and securities communities. iCure is known as a company possessing core technology for transdermal drug delivery systems.


As of 12:30 PM on the 21st, iCure's stock price is 69,100 KRW, down 2.26% from the previous day, with a trading volume of 663,201 shares, which is about 29.03% of the 5-day average trading volume.


In addition to iCure, posts from investors are also surging regarding Woori Bio (082850), SY (109610), and Sambu Construction (001470).



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing